October Newsletter 2023
Low dose of aspirin to reduce breast cancer risk?
It has been suggested that a low dose of aspirin taken daily could potentially reduce the risk of developing breast cancer in women who are at high risk, by inhibiting platelet aggregation (clumping together of platelets in the blood).
Prof Cairat and colleagues (Gustave Roussy in France) conducted a nationwide case-control study in Denmark to evaluate the association between antiplatelet drugs and breast cancer risk.
Multivariable analysis showed no association. it's important to note that aspirin can have side effects, such as increased risk of bleeding.
Natural blood thinners includes ginger, turmeric, cinnamon, MSM, bromelain and magnesium. This goes hand-in-hand with an anti-inflammatory diet.
Krill oil protects neurons from age-related degeneration
Lipid extracts from Antarctic krill are rich in long-chain omega-3 fatty acids choline, and astaxanthin. In this new study, researchers found that krill oil protects dopaminergic neurons from aging-related degeneration, decreases alpha-synuclein aggregation, and improves dopamine-dependent behaviour and cognition.
Dementia benefit of the Mediterranean diet – big study
The Mediterranean-type diet is rich in foods such as seafood, fruit, and nuts. As revealed in a new study, this diet may help reduce the risk of dementia by 23%. Scientists analysed data from 60 298 individuals and this research was published in BMC Medicine. The results are really meaningful as they are independent of genetic risk, underlining the importance of diet in dementia prevention interventions.
Finding ways to reduce our risk of developing dementia should be a priority.
Now, antacids must carry ‘acute kidney injury’ warning
A directive was issued by India’s Drugs Controller General on Tuesday, asking all state regulatory authorities to direct manufacturers of Proton Pump Inhibitors (PPIs) — a large chunk of antacid market — to incorporate ‘acute kidney injury’ as an adverse drug reaction. The warning will be inserted in the packaging of these formulations, including Pantoprazole, Omeprazole, Lansoprazole, Esomeprazole, and their combinations.
Recent global studies on anti-acidity pills (used for treating heartburn) have pointed out that there can be serious adverse events due to their prolonged use like long-term kidney damage, acute renal disease and chronic kidney disease, and in certain cases, even gastric cancer.
Since these reports are mostly restricted to nephrology journals, many physicians may not be aware of these adverse effects, experts pointed out.